211 related articles for article (PubMed ID: 18442981)
21. FW-04-806 inhibits proliferation and induces apoptosis in human breast cancer cells by binding to N-terminus of Hsp90 and disrupting Hsp90-Cdc37 complex formation.
Huang W; Ye M; Zhang LR; Wu QD; Zhang M; Xu JH; Zheng W
Mol Cancer; 2014 Jun; 13():150. PubMed ID: 24927996
[TBL] [Abstract][Full Text] [Related]
22. Two-dimensional blue native/SDS-PAGE analysis reveals heat shock protein chaperone machinery involved in hepatitis B virus production in HepG2.2.15 cells.
Liu K; Qian L; Wang J; Li W; Deng X; Chen X; Sun W; Wei H; Qian X; Jiang Y; He F
Mol Cell Proteomics; 2009 Mar; 8(3):495-505. PubMed ID: 18984579
[TBL] [Abstract][Full Text] [Related]
23. Additive viability-loss following hsp70/hsc70 double interference and Hsp90 inhibition in two breast cancer cell lines.
Håvik B; Bramham CR
Oncol Rep; 2007 Jun; 17(6):1501-10. PubMed ID: 17487411
[TBL] [Abstract][Full Text] [Related]
24. Virtual screening based identification of miltefosine and octenidine as inhibitors of heat shock protein 90.
Li L; Yang M; Li C; Liu Y
Naunyn Schmiedebergs Arch Pharmacol; 2021 Nov; 394(11):2223-2232. PubMed ID: 34406420
[TBL] [Abstract][Full Text] [Related]
25. Effective targeting of triple-negative breast cancer cells by PF-4942847, a novel oral inhibitor of Hsp 90.
Mehta PP; Whalen P; Baxi SM; Kung PP; Yamazaki S; Yin MJ
Clin Cancer Res; 2011 Aug; 17(16):5432-42. PubMed ID: 21715568
[TBL] [Abstract][Full Text] [Related]
26. BIIB021, an orally available, fully synthetic small-molecule inhibitor of the heat shock protein Hsp90.
Lundgren K; Zhang H; Brekken J; Huser N; Powell RE; Timple N; Busch DJ; Neely L; Sensintaffar JL; Yang YC; McKenzie A; Friedman J; Scannevin R; Kamal A; Hong K; Kasibhatla SR; Boehm MF; Burrows FJ
Mol Cancer Ther; 2009 Apr; 8(4):921-9. PubMed ID: 19372565
[TBL] [Abstract][Full Text] [Related]
27. Hsc70/Hsp40 chaperone system mediates the Hsp90-dependent refolding of firefly luciferase.
Minami Y; Minami M
Genes Cells; 1999 Dec; 4(12):721-9. PubMed ID: 10620017
[TBL] [Abstract][Full Text] [Related]
28. Substrate transfer from the chaperone Hsp70 to Hsp90.
Wegele H; Wandinger SK; Schmid AB; Reinstein J; Buchner J
J Mol Biol; 2006 Feb; 356(3):802-11. PubMed ID: 16403523
[TBL] [Abstract][Full Text] [Related]
29. Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions.
Walerych D; Olszewski MB; Gutkowska M; Helwak A; Zylicz M; Zylicz A
Oncogene; 2009 Dec; 28(48):4284-94. PubMed ID: 19749793
[TBL] [Abstract][Full Text] [Related]
30. Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo.
Tran PL; Kim SA; Choi HS; Yoon JH; Ahn SG
BMC Cancer; 2010 Jun; 10():276. PubMed ID: 20537126
[TBL] [Abstract][Full Text] [Related]
31. HSP90 inhibitor, celastrol, arrests human monocytic leukemia cell U937 at G0/G1 in thiol-containing agents reversible way.
Peng B; Xu L; Cao F; Wei T; Yang C; Uzan G; Zhang D
Mol Cancer; 2010 Apr; 9():79. PubMed ID: 20398364
[TBL] [Abstract][Full Text] [Related]
32. A compound that inhibits the HOP-Hsp90 complex formation and has unique killing effects in breast cancer cell lines.
Pimienta G; Herbert KM; Regan L
Mol Pharm; 2011 Dec; 8(6):2252-61. PubMed ID: 21882818
[TBL] [Abstract][Full Text] [Related]
33. Combined inhibition of heat shock proteins 90 and 70 leads to simultaneous degradation of the oncogenic signaling proteins involved in muscle invasive bladder cancer.
Cavanaugh A; Juengst B; Sheridan K; Danella JF; Williams H
Oncotarget; 2015 Nov; 6(37):39821-38. PubMed ID: 26556859
[TBL] [Abstract][Full Text] [Related]
34. Gephyromycin C, a novel small-molecule inhibitor of heat shock protein Hsp90, induces G2/M cell cycle arrest and apoptosis in PC3 cells in vitro.
Ding WJ; Ji YY; Jiang YJ; Ying WJ; Fang ZY; Gao TT
Biochem Biophys Res Commun; 2020 Oct; 531(3):377-382. PubMed ID: 32800334
[TBL] [Abstract][Full Text] [Related]
35. Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
Le Bihan S; Marsaud V; Mercier-Bodard C; Baulieu EE; Mader S; White JH; Renoir JM
Mol Endocrinol; 1998 Jul; 12(7):986-1001. PubMed ID: 9658403
[TBL] [Abstract][Full Text] [Related]
36. Antiproliferative effect of HSP90 inhibitor Y306zh against pancreatic cancer is mediated by interruption of AKT and MAPK signaling pathways.
Xue N; Jin J; Liu D; Yan R; Zhang S; Yu X; Chen X
Curr Cancer Drug Targets; 2014; 14(7):671-83. PubMed ID: 25219422
[TBL] [Abstract][Full Text] [Related]
37. The human cytosolic molecular chaperones hsp90, hsp70 (hsc70) and hdj-1 have distinct roles in recognition of a non-native protein and protein refolding.
Freeman BC; Morimoto RI
EMBO J; 1996 Jun; 15(12):2969-79. PubMed ID: 8670798
[TBL] [Abstract][Full Text] [Related]
38. Hsp90 and Hsp70 chaperones: Collaborators in protein remodeling.
Genest O; Wickner S; Doyle SM
J Biol Chem; 2019 Feb; 294(6):2109-2120. PubMed ID: 30401745
[TBL] [Abstract][Full Text] [Related]
39. Cooperative action of Hsp70, Hsp90, and DnaJ proteins in protein renaturation.
Schumacher RJ; Hansen WJ; Freeman BC; Alnemri E; Litwack G; Toft DO
Biochemistry; 1996 Nov; 35(47):14889-98. PubMed ID: 8942653
[TBL] [Abstract][Full Text] [Related]
40. Targeting Hsp90/Hsp70-based protein quality control for treatment of adult onset neurodegenerative diseases.
Pratt WB; Gestwicki JE; Osawa Y; Lieberman AP
Annu Rev Pharmacol Toxicol; 2015; 55():353-71. PubMed ID: 25292434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
